SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Transkaryotic(tktx)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
122 13 0 TKTX
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
72TKT Receives FDA Complete Review Letter on Replagal(TM PR Newswire, 01/3/2001 18Souze-1/4/2001
71TKT Files IND to Begin Clinical Testing of Iduronate-2- Sulfatase for the TreatmSouze-1/2/2001
70From today's wsj online: "Genzyme General's share price fell afterSouze-12/28/2000
69TKT Files Shelf Registration Statement and Adopts Shareholder Rights Plan PR NewSouze-12/13/2000
68TKT Regains Rights to Second Gene-Activated(R) Protein From Aventis Pharma PR NeSouze-12/8/2000
67TKT Reports Encouraging Results in First Human Investigation Of Hemophilia A GenSouze-12/5/2000
66TRANSKARYOTIC THERAPIES INC has filed a Form SC 13G (Statement of Beneficial OwnSouze-11/29/2000
65<i>PHILADELPHIA, Oct 5, 2000 /PRNewswire via COMTEX/ -- Transkaryotic TherSouze-10/5/2000
64Quite a spike at 2 p.m. quote.bloomberg.comgreedsgd_2000-9/6/2000
63This is a little old, but maybe still useful: <i>Reuters, 09/1/2000 13:18Souze-9/5/2000
62Trial grinds to close, outcome unclear biz.yahoo.com martinJongmans-7/28/2000
61biz.yahoo.comopalapril-7/25/2000
60TKTX Announces Acceptance of MAA in Europe for Replagal biz.yahoo.com martinJongmans-7/20/2000
59TKTX Forms European Company to Market Niche Protein Products-TKTX Europe-5S ABB Jongmans-7/17/2000
58Genentech CEO Says: "AMGN/TKTX Trial-outcome Not a Bellwether for Biotech&qJongmans-7/14/2000
57TKTX Witness Says Protein Not Same as AMGEN's WSJ Interactive (RegistrationJongmans-7/7/2000
56Reuters: Trial past mid-point, too close to call biz.yahoo.com martinJongmans-7/7/2000
55Yes, the trial continues today. Here's the rest of that Dow Jones article, Souze-7/7/2000
54TKTX,Aventis (have) Resume(d) Defense Against AMGN in Trial Article Boston GlobJongmans-7/7/2000
53A quote from the end of the NYT article for which you gave a link: <i>&quSouze-7/3/2000
52test mJongmans-7/2/2000
51The Gene Angle on Medical Shares Article NY Times www10.nytimes.com martinJongmans-7/2/2000
50 From today's WSJ online:June 28, 2000 Personalized E-Mail --------------Souze-6/29/2000
49 Boston Globe/TKTX/Fabry boston.com martinJongmans-6/17/2000
48 TKTX Submits Biologics License Application fot Replagan (TM) to Treat Fabry DiJongmans-6/16/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News